N-(2-hydroxyphenyl)-4-(phenylsulfanyl)butanamide | 1608158-05-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-hydroxyphenyl)-4-(phenylsulfanyl)butanamide
• 英文别名: N-(2-hydroxyphenyl)-4-phenylsulfanylbutanamide
• CAS: 1608158-05-9
• 化学式: C₁₆H₁₇NO₂S
• 分子量: 287.382
• InChiKey: RSJUFFZQMPQHRP-UHFFFAOYSA-N

物化性质

• 沸点：
  511.2±35.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  methyl 4-(phenylthio)butanoate 在 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 potassium hydroxide 作用下， 以 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 24.0h， 生成 N-(2-hydroxyphenyl)-4-(phenylsulfanyl)butanamide
  参考文献：
  名称：

  [EN] CLASS OF HDAC INHIBITORS EXPANDS THE RENAL PROGENITOR CELLS POPULATION AND IMPROVES THE RATE OF RECOVERY FROM ACUTE KIDNEY INJURY
  [FR] CLASSE D'INHIBITEURS DE HDAC MULTIPLIANT LA POPULATION DE CELLULES PROGÉNITRICES RÉNALES ET AMÉLIORANT LE TAUX DE RÉCUPÉRATION APRÈS UNE INSUFFISANCE RÉNALE AIGÜE

  摘要：

  提供了抑制组蛋白去乙酰化酶活性的化合物和组合物，这些化合物和组合物可以扩大肾脏祖细胞群体，并改善受损肾脏的功能。提供了这些化合物和组合物的使用方法。

  公开号：

  WO2014071000A1

文献信息

• Class of HDAC Inhibitors Expands the Renal Progenitor Cells Population and Improves the Rate of Recovery from Acute Kidney Injury
  申请人：UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

  公开号：US20150246939A1

  公开（公告）日：2015-09-03

  Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.

  本发明提供了抑制组蛋白去乙酰化酶活性的化合物和组合物，这些化合物和组合物可以扩大肾脏前体细胞种群并改善受损肾脏的功能。同时，本发明还提供了使用这些化合物和组合物的方法。
• Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
  申请人：University of Pittsburgh—Of the Commonwealth System of Higher Education

  公开号：US10233201B2

  公开（公告）日：2019-03-19

  Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.

  本研究提供了抑制组蛋白脱乙酰酶活性的化合物和组合物，这些化合物和组合物能扩大肾脏祖细胞群，改善受损肾脏的肾功能。还提供了使用这些化合物和组合物的方法。
• METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
  申请人：Design Therapeutics, Inc.

  公开号：US20210238226A1

  公开（公告）日：2021-08-05

  The present disclosure relates to compounds and methods for modulating the expression of dmpk, atxn1, atxn2, atxn3, cacna1a, atxn7, ppp2r2br tbp, htt, jph3r ar, or atn1 and treating diseases and conditions in which dmpk, atxn1, atxn2, atxn3, cacna1a, atxn1, ppp2r2b, tbp, htt, jph3, ar, or atn1 plays an active role. The compound can be a transcription modulator molecule having a first terminus, a second terminus, and oligomeric backbone, wherein: a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CAG or CTG; b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CAG or CTG; and c) the oligomeric backbone comprising a linker between the first terminus and the second terminus.
• Methods of Treatment of Kidney Injury Associated with Infection or Trauma
  申请人：University of Pittsburgh - Of the Commonwealth System of Higher Education

  公开号：US20220226266A1

  公开（公告）日：2022-07-21

  Provided herein is a method of treating kidney injury associated with trauma or infection, such as in sepsis-associated acute kidney injury.
• US9670236B2
  申请人：——

  公开号：US9670236B2

  公开（公告）日：2017-06-06